6E2Q

Structure of human JAK2 FERM/SH2 in complex with Erythropoietin Receptor

6E2Q の概要

• エントリーDOI: 10.2210/pdb6e2q/pdb
• 分子名称: Tyrosine-protein kinase JAK2, Erythropoietin receptor (3 entities in total)
• 機能のキーワード: cytokine receptor, erythropoietin, signal transduction, signaling protein
• 由来する生物種: Homo sapiens (Human); 詳細
• タンパク質・核酸の鎖数: 8
• 化学式量合計: 258977.05

構造登録者

Ferrao, R.,Lupardus, P.J. (登録日: 2018-07-11, 公開日: 2018-08-08, 最終更新日: 2023-10-11)

主引用文献

Ferrao, R.D.,Wallweber, H.,Lupardus, P.J.
Receptor-mediated dimerization of JAK2 FERM domains is required for JAK2 activation.
Elife, 7:-, 2018

PubMed Abstract: Cytokines and interferons initiate intracellular signaling via receptor dimerization and activation of Janus kinases (JAKs). How JAKs structurally respond to changes in receptor conformation induced by ligand binding is not known. Here, we present two crystal structures of the human JAK2 FERM and SH2 domains bound to Leptin receptor (LEPR) and Erythropoietin receptor (EPOR), which identify a novel dimeric conformation for JAK2. This 2:2 JAK2/receptor dimer, observed in both structures, identifies a previously uncharacterized receptor interaction essential to dimer formation that is mediated by a membrane-proximal peptide motif called the 'switch' region. Mutation of the receptor switch region disrupts STAT phosphorylation but does not affect JAK2 binding, indicating that receptor-mediated formation of the JAK2 FERM dimer is required for kinase activation. These data uncover the structural and molecular basis for how a cytokine-bound active receptor dimer brings together two JAK2 molecules to stimulate JAK2 kinase activity.

PubMed: 30044226
DOI: 10.7554/eLife.38089

実験手法

X-RAY DIFFRACTION (2.65 Å)